130 related articles for article (PubMed ID: 14642783)
1. Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test.
Yamamoto T; Saito O; Shono K; Hirasawa S
Eur J Pharmacol; 2003 Nov; 481(2-3):175-80. PubMed ID: 14642783
[TBL] [Abstract][Full Text] [Related]
2. Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats.
Kajiyama S; Kawamoto M; Shiraishi S; Gaus S; Matsunaga A; Suyama H; Yuge O
Brain Res; 2005 May; 1044(1):76-86. PubMed ID: 15862792
[TBL] [Abstract][Full Text] [Related]
3. Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test.
Yamamoto T; Nozaki-Taguchi N; Chiba T
Br J Pharmacol; 2002 Sep; 137(2):170-6. PubMed ID: 12208773
[TBL] [Abstract][Full Text] [Related]
4. [Orexins and pain processing].
Yamamoto T; Shono K
Masui; 2007 Jan; 56(1):40-7. PubMed ID: 17243644
[TBL] [Abstract][Full Text] [Related]
5. Orexin-A, an hypothalamic peptide with analgesic properties.
Bingham S; Davey PT; Babbs AJ; Irving EA; Sammons MJ; Wyles M; Jeffrey P; Cutler L; Riba I; Johns A; Porter RA; Upton N; Hunter AJ; Parsons AA
Pain; 2001 May; 92(1-2):81-90. PubMed ID: 11323129
[TBL] [Abstract][Full Text] [Related]
6. Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement.
Duxon MS; Stretton J; Starr K; Jones DN; Holland V; Riley G; Jerman J; Brough S; Smart D; Johns A; Chan W; Porter RA; Upton N
Psychopharmacology (Berl); 2001 Jan; 153(2):203-9. PubMed ID: 11205420
[TBL] [Abstract][Full Text] [Related]
7. Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain.
Cheng JK; Chou RC; Hwang LL; Chiou LC
J Pharmacol Exp Ther; 2003 Dec; 307(3):1065-71. PubMed ID: 14551290
[TBL] [Abstract][Full Text] [Related]
8. Anti-hyperalgesic effects of intrathecally administered neuropeptide W-23, and neuropeptide B, in tests of inflammatory pain in rats.
Yamamoto T; Saito O; Shono K; Tanabe S
Brain Res; 2005 May; 1045(1-2):97-106. PubMed ID: 15910767
[TBL] [Abstract][Full Text] [Related]
9. Excitatory amino acid receptor antagonists and electroacupuncture synergetically inhibit carrageenan-induced behavioral hyperalgesia and spinal fos expression in rats.
Zhang YQ; Ji GC; Wu GC; Zhao ZQ
Pain; 2002 Oct; 99(3):525-535. PubMed ID: 12406529
[TBL] [Abstract][Full Text] [Related]
10. Analgesic effects of intrathecally administered 26RFa, an intrinsic agonist for GPR103, on formalin test and carrageenan test in rats.
Yamamoto T; Wada T; Miyazaki R
Neuroscience; 2008 Nov; 157(1):214-22. PubMed ID: 18824219
[TBL] [Abstract][Full Text] [Related]
11. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats.
Haynes AC; Jackson B; Chapman H; Tadayyon M; Johns A; Porter RA; Arch JR
Regul Pept; 2000 Dec; 96(1-2):45-51. PubMed ID: 11102651
[TBL] [Abstract][Full Text] [Related]
12. Anti-allodynic effects of intrathecally and intracerebroventricularly administered 26RFa, an intrinsic agonist for GRP103, in the rat partial sciatic nerve ligation model.
Yamamoto T; Miyazaki R; Yamada T; Shinozaki T
Peptides; 2011 Jun; 32(6):1262-9. PubMed ID: 21439338
[TBL] [Abstract][Full Text] [Related]
13. Spinal 5-HT1A, not the 5-HT1B or 5-HT3 receptors, mediates descending serotonergic inhibition for late-phase mechanical allodynia of carrageenan-induced peripheral inflammation.
Kim JM; Jeong SW; Yang J; Lee SH; Kim WM; Jeong S; Bae HB; Yoon MH; Choi JI
Neurosci Lett; 2015 Jul; 600():91-7. PubMed ID: 26037417
[TBL] [Abstract][Full Text] [Related]
14. Orexin-2 receptors inhibit primary afferent fiber-evoked responses of ventral roots in the neonatal rat isolated spinal cord.
Shono K; Yamamoto T
Brain Res; 2008 Jul; 1218():97-102. PubMed ID: 18511021
[TBL] [Abstract][Full Text] [Related]
15. Involvement of spinal orexin A in the electroacupuncture analgesia in a rat model of post-laparotomy pain.
Feng XM; Mi WL; Xia F; Mao-Ying QL; Jiang JW; Xiao S; Wang ZF; Wang YQ; Wu GC
BMC Complement Altern Med; 2012 Nov; 12():225. PubMed ID: 23173601
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area.
Bartsch T; Levy MJ; Knight YE; Goadsby PJ
Pain; 2004 Jun; 109(3):367-378. PubMed ID: 15157698
[TBL] [Abstract][Full Text] [Related]
17. Involvement of spinal neurokinin-1 receptors in the maintenance but not induction of carrageenan-induced thermal hyperalgesia in the rat.
Gao YJ; Zhang YQ; Zhao ZQ
Brain Res Bull; 2003 Oct; 61(6):587-93. PubMed ID: 14519455
[TBL] [Abstract][Full Text] [Related]
18. The role of spinal orexin-1 receptors in posterior hypothalamic modulation of neuropathic pain.
Jeong Y; Holden JE
Neuroscience; 2009 Apr; 159(4):1414-21. PubMed ID: 19409203
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice.
Mobarakeh JI; Takahashi K; Sakurada S; Nishino S; Watanabe H; Kato M; Yanai K
Peptides; 2005 May; 26(5):767-77. PubMed ID: 15808907
[TBL] [Abstract][Full Text] [Related]
20. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats.
Rodgers RJ; Halford JC; Nunes de Souza RL; Canto de Souza AL; Piper DC; Arch JR; Upton N; Porter RA; Johns A; Blundell JE
Eur J Neurosci; 2001 Apr; 13(7):1444-52. PubMed ID: 11298806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
